Stay updated on Selpercatinib in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Selpercatinib in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Selpercatinib in Advanced Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedMedullary thyroid carcinoma term added to the study conditions. Genetic and Rare Diseases Information Center resources added.SummaryDifference0.1%

- Check12 days agoChange DetectedRevision: v3.5.0; Revision: v3.4.3 removed. The update appears to be an internal version bump with no visible changes to the study page content in the provided screenshots.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedPage revision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check41 days agoChange DetectedResults status on the study page changed from 'No Results Posted' to 'Results Submitted'. This clarifies the availability of trial results for review by researchers, clinicians, and potential participants.SummaryDifference0.0%

- Check49 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed, indicating a minor site version update. This change does not affect the study details, enrollment, or other user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed.SummaryDifference0.0%

Stay in the know with updates to Selpercatinib in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selpercatinib in Advanced Solid Tumors Clinical Trial page.